Cargando…

Clinical and population‐based study design considerations to accelerate the investigation of new antiretrovirals during pregnancy

INTRODUCTION: Pregnant women are routinely excluded from clinical trials, leading to the absence or delay in even the most basic pharmacokinetic (PK) information needed for dosing in pregnancy. When available, pregnancy PK studies use a small sample size, resulting in limited safety information. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brummel, Sean S., Stringer, Jeff, Mills, Ed, Tierney, Camlin, Caniglia, Ellen C., Colbers, Angela, Chi, Benjamin H., Best, Brookie M., Gaaloul, Myriam El, Hillier, Sharon, Jourdain, Gonzague, Khoo, Saye H., Mofenson, Lynne M., Myer, Landon, Nachman, Sharon, Stranix‐Chibanda, Lynda, Clayden, Polly, Sachikonye, Memory, Lockman, Shahin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294861/ https://www.ncbi.nlm.nih.gov/pubmed/35851758 http://dx.doi.org/10.1002/jia2.25917

Ejemplares similares

What will it take to bring LAED medication regimens to young people?
por: Hosek, Sybil, et al.
Publicado: (2023)

Accelerating investigation of new HIV drugs in pregnancy: advancing the research agenda from theory to action
por: Penazzato, Martina, et al.
Publicado: (2022)

Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial
por: Stranix-Chibanda, Lynda, et al.
Publicado: (2021)

Bone and Renal Health in Infants With or Without Breastmilk Exposure to Tenofovir-Based Maternal Antiretroviral Treatment in the PROMISE Randomized Trial
por: Vhembo, Tichaona, et al.
Publicado: (2023)

Editorial: mHealth Interventions for Improving Adolescent Sexual and Reproductive Health
por: Johnson, Amy K., et al.
Publicado: (2022)

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial
por: Baltrusaitis, Kristin, et al.
Publicado: (2022)

Effect of Pregnancy and Concomitant Antiretrovirals on the Pharmacokinetics of Tenofovir in Women With HIV Receiving Tenofovir Disoproxil Fumarate‐Based Antiretroviral Therapy Versus Women With HBV Receiving Tenofovir Disoproxil Fumarate Monotherapy
por: Bukkems, Vera E., et al.
Publicado: (2020)

Inclusion of pregnant women in antiretroviral drug research: what is needed to move forwards?
por: Fairlie, Lee, et al.
Publicado: (2019)

Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities
por: Nachman, Sharon, et al.
Publicado: (2019)

Antibodies for HIV prevention: the path forward
por: Malhotra, Shelly, et al.
Publicado: (2023)

A retrospective analysis of incident pregnancy in phase 1 and 2a HIV-1 vaccine study participants does not support concern for adverse pregnancy or birth outcomes
por: Stranix-Chibanda, Lynda, et al.
Publicado: (2021)

Factors associated with access to HIV care and treatment in a prevention of mother to child transmission programme in urban Zimbabwe
por: Muchedzi, Auxilia, et al.
Publicado: (2010)

Cost-Effectiveness of Pre-exposure HIV Prophylaxis During Pregnancy and Breastfeeding in Sub-Saharan Africa
por: Price, Joan T., et al.
Publicado: (2016)

Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial
por: Stranix-Chibanda, Lynda, et al.
Publicado: (2021)

Innovative Approaches for Pharmacology Studies in Pregnant and Lactating Women: A Viewpoint and Lessons from HIV
por: Eke, Ahizechukwu C., et al.
Publicado: (2020)

“It’s only fatness, it doesn’t kill”: a qualitative study on perceptions of weight gain from use of dolutegravir-based regimens in women living with HIV in Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022)

‘I fear my partner will abandon me’: the intersection of late initiation of antenatal care in pregnancy and poor ART adherence among women living with HIV in South Africa and Uganda
por: Alhassan, Yussif, et al.
Publicado: (2022)

The feasibility of preventing mother-to-child transmission of HIV using peer counselors in Zimbabwe
por: Shetty, Avinash K, et al.
Publicado: (2008)

Obstetric Pharmacokinetic Dosing Studies are Urgently Needed
por: McCormack, Shelley A., et al.
Publicado: (2014)

Emerging evidence from a systematic review of safety of pre‐exposure prophylaxis for pregnant and postpartum women: where are we now and where are we heading?
por: Joseph Davey, Dvora L, et al.
Publicado: (2020)

Cost‐effectiveness of broadly neutralizing antibody prophylaxis for HIV‐exposed infants in sub‐Saharan African settings
por: Dugdale, Caitlin M., et al.
Publicado: (2023)

Intake of Raw Fruits and Vegetables Is Associated With Better Mental Health Than Intake of Processed Fruits and Vegetables
por: Brookie, Kate L., et al.
Publicado: (2018)

Current progress in the prevention of mother-to-child transmission of hepatitis B and resulting clinical and programmatic implications
por: Jourdain, Gonzague, et al.
Publicado: (2019)

Factors associated with unsuppressed viremia in women living with HIV on lifelong ART in the multi-country US-PEPFAR PROMOTE study: A cross-sectional analysis
por: Atuhaire, Patience, et al.
Publicado: (2019)

Factors associated with testing for HIV in people aged ≥50 years: a qualitative study
por: Youssef, Elaney, et al.
Publicado: (2018)

Factors associated with HIV testing in people aged ⩾50 years: an integrated qualitative analysis of patients and healthcare providers
por: Youssef, Elaney, et al.
Publicado: (2023)

Analytical Treatment Interruption in HIV Trials: Statistical and Study Design Considerations
por: Zheng, Lu, et al.
Publicado: (2021)

Optimizing responses to drug safety signals in pregnancy: the example of dolutegravir and neural tube defects
por: Mofenson, Lynne M, et al.
Publicado: (2019)

Associations between plasma nucleoside reverse transcriptase inhibitors concentrations and cognitive function in people with HIV
por: De Francesco, Davide, et al.
Publicado: (2021)

The ADVANCE study: a groundbreaking trial to evaluate a candidate universal antiretroviral regimen
por: Venter, Willem D.F., et al.
Publicado: (2017)

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women
por: Schalkwijk, Stein, et al.
Publicado: (2018)

Approaches to accelerating the study of new antiretrovirals in pregnancy
por: Abrams, Elaine J., et al.
Publicado: (2022)

Impaired Bone Architecture in Peripubertal Children With HIV, Despite Treatment With Antiretroviral Therapy: A Cross‐Sectional Study From Zimbabwe
por: Mukwasi‐Kahari, Cynthia, et al.
Publicado: (2022)

Evaluation of the First Year of a Pilot Program in Community Pharmacy: HIV/AIDS Medication Therapy Management for Medi-Cal Beneficiaries
por: Hirsch, Jan D., et al.
Publicado: (2009)

Etravirine Pharmacokinetics in HIV-Infected Pregnant Women
por: Mulligan, Nikki, et al.
Publicado: (2016)

Optimizing Pharmacology Studies in Pregnant and Lactating Women Using Lessons From HIV: A Consensus Statement
por: Eke, Ahizechukwu C., et al.
Publicado: (2020)

Antiretroviral Therapy Adherence During and Postbreastfeeding Cessation Measured by Tenofovir Levels in Hair
por: Nematadzira, Teacler G., et al.
Publicado: (2022)

Safety and pharmacokinetics of dolutegravir in HIV-positive pregnant women: a systematic review
por: Hill, Andrew, et al.
Publicado: (2018)

Prevention of mother-to-child transmission of hepatitis B virus: a phase III, placebo-controlled, double-blind, randomized clinical trial to assess the efficacy and safety of a short course of tenofovir disoproxil fumarate in women with hepatitis B virus e-antigen
por: Jourdain, Gonzague, et al.
Publicado: (2016)

Seasonality of adverse birth outcomes in women with and without HIV in a representative birth outcomes surveillance study in Botswana
por: Caniglia, Ellen C, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_thiitd78fcttg8h2hl3d32v31d